Technical Analysis for EIGR - Eiger BioPharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade A 12.87 1.34% 0.17
EIGR closed up 1.34 percent on Wednesday, January 16, 2019, on 72 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
1 Watcher
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical EIGR trend table...

Date Alert Name Type % Chg
Jan 16 Hammer Candlestick Bullish 0.00%
Jan 16 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Jan 16 Pocket Pivot Bullish Swing Setup 0.00%
Jan 16 Outside Day Range Expansion 0.00%
Jan 16 Wide Bands Range Expansion 0.00%
Jan 16 Overbought Stochastic Strength 0.00%
Jan 15 New Uptrend Bullish 1.34%
Jan 15 Narrow Range Bar Range Contraction 1.34%
Jan 15 NR7 Range Contraction 1.34%
Jan 15 Wide Bands Range Expansion 1.34%

Older signals for EIGR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
Basic chart:

Profile
Eiger BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops a portfolio of late-stage drugs for orphan diseases. It offers Sarasar, which is used for the treatment of hepatitis delta; Exendin that is used for the treatment of hypoglycemia; and Bestatin, which is used for the treatment of pulmonary arterial hypertension and lymphedema. Eiger BioPharmaceuticals, Inc. was founded in 2008 and is based in Palo Alto, California.
Is EIGR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jan 7 Eiger BioPharmaceuticals Appoints Regulatory Expert and Industry Veteran Christine Murray, MS, RAC to its Board of Directors
Dec 31 Report: Exploring Fundamental Drivers Behind Cronos Group, Henry Schein, Argo Group International, Eiger BioPharmaceuticals, China Automotive, and Moleculin Biotech — New Horizons, Emerging Trends, and Upcoming Developments
Dec 21 Have Insiders Been Buying Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Shares?
Dec 19 FDA grants accelerated review status for Eiger Bio's lonafarnib for rare accelerated aging disorder
Dec 19 Eiger Announces Breakthrough Therapy Designation Granted by FDA for Lonafarnib in Progeria and Progeroid Laminopathies
Dec 18 Eiger Announces PRIME Designation Granted by European Medicines Agency for Lonafarnib for Treatment of Hepatitis Delta Virus Infection
Dec 17 Eiger Bio's lonafarnib nabs accelerated review status in U.S. for HDV infection
Dec 17 Eiger Announces Breakthrough Therapy Designation Granted by FDA for Lonafarnib for Treatment of Hepatitis Delta Virus (HDV) Infection
Dec 11 Eiger BioPharmaceuticals Reports on 2018 R&D Day
Dec 4 Eiger BioPharmaceuticals to Host R&D Day in New York City
See more EIGR news...
Indicators
Indicator Value
52 Week High 18.0
52 Week Low 7.46
Average Volume 145,901
200-Day Moving Average 11.4003
50-Day Moving Average 10.8044
20-Day Moving Average 11.1055
10-Day Moving Average 12.343
Average True Range 0.7235
ADX 27.07
+DI 27.834
-DI 11.5611
Chandelier Exit (Long, 3 ATRs ) 11.0945
Chandelier Exit (Short, 3 ATRs ) 10.9805
Upper Bollinger Band 13.9099
Lower Bollinger Band 8.3011
Percent B (%b) 0.81
BandWidth 50.504705
MACD Line 0.6443
MACD Signal Line 0.4136
MACD Histogram 0.2307
Fundamentals Value
Market Cap 107.69 Million
Num Shares 8.37 Million
EPS -5.68
Price-to-Earnings (P/E) Ratio -2.27
Price-to-Sales 0.00
Price-to-Book 4.37
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.47
Resistance 3 (R3) 13.41 13.16 13.37
Resistance 2 (R2) 13.16 13.00 13.19 13.34
Resistance 1 (R1) 13.01 12.91 13.09 13.07 13.30
Pivot Point 12.76 12.76 12.79 12.79 12.76
Support 1 (S1) 12.61 12.60 12.69 12.67 12.44
Support 2 (S2) 12.36 12.51 12.39 12.40
Support 3 (S3) 12.21 12.36 12.37
Support 4 (S4) 12.27